[Form 4] Viemed Healthcare, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Randy E. Dobbs, a director of Viemed Healthcare, Inc. (VMD), reported changes in his beneficial ownership of the issuer's common stock on transactions dated 08/19/2025 and 08/20/2025. The filing shows a grant and vesting activity: Restricted Stock Units (RSUs) and Phantom Share Units were granted on 08/19/2025 (16,763 RSUs and 4,191 phantom units) that vest on 08/19/2026, and RSUs granted on 08/20/2024 that vest on 08/20/2025 are referenced in the explanations.

The reported result of the 08/20/2025 activity is an acquisition entry of 17,784 common shares (code M) and a reported total of 125,490 shares beneficially owned following the reported transaction(s). The filing was signed by an attorney-in-fact on 08/20/2025.

Insights

Corporate Governance Expert

TL;DR: Routine director equity grants and a vesting-related acquisition increased direct shareholdings to 125,490 shares.

The Form 4 documents standard director compensation and vesting events rather than an opportunistic open-market purchase or sale. The 08/19/2025 grants (16,763 RSUs and 4,191 phantom units) with first-anniversary vesting are consistent with typical retention awards. The 08/20/2025 entry recording 17,784 shares acquired (code M) aligns with a vesting/settlement event tied to prior RSU grants. For governance reviewers this is informational about insider alignment with shareholders but not an unusual corporate governance event.

Compensation Analyst

TL;DR: Pay design shows time-vested equity and cash-settled phantom units to retain a director through at least one year.

The mix of restricted stock units and phantom share units indicates a combination of equity- and cash-based retention compensation. RSUs granted on 08/19/2025 vest on 08/19/2026, and phantom units granted the same date vest on the same schedule, which staggers future dilution and cash obligations. The vesting/settlement reflected on 08/20/2025 (17,784 shares) appears tied to an earlier grant that vested, increasing reported direct holdings to 125,490 shares. Overall, this is routine compensation administration rather than a material corporate event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dobbs Randy E.

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/20/2025		M		17,784	A	(1)	125,490	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/20/2025		M			17,784	(2)	(2)	Common Shares	17,784	$0	0	D
Restricted Stock Units	(1)	08/19/2025		A		16,763		(3)	08/19/2026	Common Shares	16,763	$0	16,763	D
Phantom Share Units	(4)	08/19/2025		A		4,191		(5)	08/19/2026	Common Shares	4,191	$0	4,191	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. On August 20, 2024, the reporting person was granted Restricted Stock Units which vest on August 20, 2025.

3. Restricted Stock Units (RSUs) granted to reporting person on August 19, 2025, which vest on the first anniversary of the grant date.

4. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.

5. Represents an award granted on August 19, 2025 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Randy E. Dobbs report on Form 4 for VMD?

The Form 4 reports acquisitions and grants of RSUs and phantom units on 08/19/2025 and 08/20/2025 and shows 125,490 shares beneficially owned after the transactions.

How many Restricted Stock Units were granted to the reporting person on 08/19/2025?

The filing discloses a grant of 16,763 RSUs on 08/19/2025 that vest on 08/19/2026.

What are the phantom share units reported in the VMD Form 4?

The filing shows 4,191 phantom share units granted on 08/19/2025 under the issuer's Phantom Share Plan that vest on 08/19/2026 and pay cash value based on share price at vesting.

Did any RSUs vest or convert to shares on 08/20/2025?

The filing lists an entry dated 08/20/2025 recording an acquisition of 17,784 common shares (code M) and references RSUs granted on 08/20/2024 that vest on 08/20/2025.

Who signed the Form 4 filing for the reporting person?

The Form 4 was signed by Jesse Bergeron, Attorney-in-Fact on 08/20/2025 on behalf of the reporting person.